Mitogenic stimulation of t cells reveals differing contributions for B7-1 (CD80) and B7-2 (CD86) costimulation

Immunology

Volumn 90, Issue 4, 1997, Pages 534-542

  Perrin, P J ^a,b   Davis, T A ^a   Smoot, D S ^a   Abe, R ^a   June, C H ^a   Lee, K P ^a  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CONCANAVALIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; MESSENGER RNA;

ANIMAL CELL; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELPER CELL; LYMPH NODE CELL; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030998679     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.04.00215.x     Document Type: Article

References (44)

1. BRETSCHER P. (1992) The two-signal model of lymphocyte activation 21 years later. Immunol Today 13, 74.
2. SCHWARTZ R.H. (1990) A cell culture model for T lymphocyte clonal anergy. Science 248, 1349.
3. HARDING F.A., MCARTHUR J.G., GROSS J.A., RAULET D.H. & ALLISON J.P. (1992) CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356, 607.
4. JUNE C.H., LEDBETTER J.A., LINSLEY P.S. & THOMPSON C.B. (1990) Role of the CD28 receptor in T-cell activation. Immunol Today 11, 211.
5. FREEMAN G.J., BORRIELLO F., HODES R.J. et al. (1993) Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J Exp Med 178, 2185.
6. FREEMAN G.J., BORRIELLO F., HODES R.J. et al. (1993) Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262, 907.
7. CAUX C., VANBERVLIET B., MASSACRIER C., AZUMA M., OKUMURA K., LANIER L.L. & BANCHEREAU J. (1994) B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med 180, 1841.
8. HATHCOCK K.S., LASZLO G., PUCILLO C., LINSLEY P. & HODES R.J. (1994) Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med 180, 631.
9. SHAHINIAN A., PFEFFER K., LEE K.P. et al. (1993) Differential T cell costimulatory requirements in CD28-deficient mice. Science 261, 609.
10. GREEN J.M., NOEL P.J., SPERLING A.I. et al. (1994) Absence of B7-dependent responses in CD28-deficient mice. Immunity 1, 501.
11. THOMPSON C.B., LINDSTEN T., LEDBETTER J.A. et al. (1989) CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc Natl Acad Sci USA 86, 1333.
12. LENSCHOW D.J., ZENG Y., THISTLETHWAITE J.R. et al. (1992) Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257, 789.
13. LINSLEY P.S., WALLACE P.M., JOHNSON J. et al. (1992) Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257, 792.
14. AZUMA M., ITO D., YAGITA H. et al. (1993) B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366, 76.
15. LARSEN C.P., RITCHIE S.C., HENDRIX R. et al. (1994) Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol 152, 5208.
16. KUCHROO V., DAS M.P., BROWN J.A. et al (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80, 707.
17. LENSCHOW D.J., HO S.C., SATTAR H. et al. (1995) Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 181, 1145.
18. RACKE M.K., SCOTT D.E., QUIGLEY L., GRAY G.S., ABE R., JUNE C.H. & PERRIN P.J. (1995) Distinct roles for B7-1 (CD80) and B7-2 (CD86) in the initiation of experimental allergic encephalomyelitis. J Clin Invest 96, 2195.
19. LIS H. & SHARON N. (1987) Lectins. Methods Enzymol 150, 952.
20. SHARON N. (1983) Lectin receptors as lymphocyte surface markers. Adv Immunol 34, 213.
21. WEISS A., SHIELDS R., NEWTON M., MANGER B. & IMBODEN J. (1987) Ligand-receptor interactions required for commitment to the activation of the interleukin 2 gene. J Immunol 138, 2169.
22. AHMANN G.B., SACHS D.H. & MODES R.J. (1978) Requirement for an Ia-bearing accessory cell in Con A-induced T cell proliferation. J Immunol 121, 1981.
23. CHATILA T.A., SCHWARTZ D.H., MILLER R. & GEHA R.S. (1987) Requirement for mitogen, T cell-accessory cell contact, and interleukin 1 in the induction of resting T-cell proliferation. Clin Immunol Immunopathol 44, 235.
24. BEVERLY B., KANG, S.-M., LENARDO M.J. & SCHWARTZ R.H. (1992) Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int Immunol 4, 661.
25. FREEMAN G.J., BORRIELLO F., HODES R.J. et al. (1993) Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262, 907.
26. GIMMI C.D., FREEMAN G.J., GRIBBEN J.G., GRAY G. & NADLER L.M. (1993) Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 90, 6586.
27. RAZI WOLF Z., GALVIN F., GRAY G. & REISER H. (1993) Evidence for an additional ligand, distinct from B7, for the CTLA-4 receptor. Proc Natl Acad Sci USA 90, 11 182.
28. HATHCOCK K.S., LASZLO G., DICKLER H.B., BRADSHAW J., LINSLEY P. & HODES R.J. (1993) Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262, 905.
29. ABE R., VANDENBERGHE P., CRAIGHEAD N., SMOOT D.S., LEE K.P. & JUNE C.H. (1995) Direct signal transduction in mouse CD4 + and CD8 + splenic T cells after CD28 receptor ligation. J Immunol 154, 984.
30. JUNE C.H. & RABINOVITCH P.S. (1991) Measurement of intracellular ions by flow cytometry. In: Current Protocols in Immunology (eds J.E. Colligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach & W. Srober) p. 51. Greene and Wiley Interscience, New York.
31. LEE K.P., TAYLOR C., PETRYNIAK B., TURKA L.A., JUNE C.H. & THOMPSON C.B. (1990) The genomic organization of the CD28 gene. Implications for the regulation of CD28 mRNA expression and heterogeneity. J Immunol 145, 344.
32. JUNE C.H., LEDBETTER J.A., GILLESPIE M.M., LINDSTEN T. & THOMPSON C.B. (1987) T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol Cell Biol 7, 4472.
33. JUNE C.H., BLUESTONE J.A., NADLER L.M. & THOMPSON C.B. (1994) The B7 and CD28 receptor families. Immunol Today 15, 321.
34. FINKEL T.H., KUBO R.T. & CAMBIER J.C. (1991) T-cell development and transmembrane signaling: changing biological responses through an unchanging receptor. Immunol Today 12, 79.
35. DEREWENDA Z., YARIV J., HELLIWELL J.R. et al. (1989) The structure of the saccharide-binding site of concanavalin A. EMBO J 8, 2189.
36. ASHWELL J.D. (1988) Are B lymphocytes the principal antigen-presenting cells in vivo? J Immunol 140, 3697.
37. KURT JONES E.A., LIANO D., HAYGLASS K.A., BENACERRAF B., SY M.S. & ABBAS A.K. (1988) The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice. J Immunol 140, 3773.
38. MARCHALONIS J.J. (1987) Lectins in the isolation of receptors on lymphocytes. Methods Enzymol 150, 463.
39. CHILSON O.P., BOYLSTON A.W. & CRUMPTON M.J. (1984) Phaseolus vulgaris phytohaemagglutinin (PHA) binds to the human T lymphocyte antigen receptor. EMBO J 3, 3239.
40. LENSCHOW D.J., SU G.H., ZUCKERMAN L.A. et al. (1993) Expression and functional significance of an additional ligand for CTLA-4. Proc Natl Acad Sci USA 90, 11 054.
41. TAMURA N., ISHII N., NAKAZAWA M. et al. (1996) Requirement of CD80 and CD86 molecules for antigen presentation by eosinophils. Scand J Immunol 44, 229.
42. PRABHU DAS M.R., ZAMVIL S.S., BORRIELLO F., WEINER H.L., SHARPE A.H. & KUCHROO V.K. (1995) Reciprocal expression of co-stimulatory molecules, B7-1 and B7-2, on murine T cells following activation. Eur J Immunol 25, 207.
43. STACK R.M., LENSCHOW D.J., GRAY G.S., BLUESTONE J.A. & FITCH F.W. (1994) 1L-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2. J Immunol 152, 5723.
44. PERRIN P.J., SCOTT D., DAVIS T.A. et al. (1996) Opposing effects of CTLA4-Ig and anti-CD80 (B7-1) plus anti-CD86 (B7-2) on experimental allergic encephalomyelitis. J Neuroimmunol 65, 31.